Astrana Health Cash Flow Statement
NASDAQ: ASTHConsumer DiscretionaryProfessional ServicesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Astrana Health free cash flow
In fiscal 2025, Astrana Health generated $114.6 million of operating cash flow and spent $10.1 million on capital expenditures. That left free cash flow of $104.5 million, a free-cash-flow margin of 3.3% of revenue. Free cash flow was up 136.6% from the prior year's $44.2 million.
Astrana Health returned $33.5 million to shareholders: $7.9 million in dividends and $25.6 million in share repurchases, equal to 32% of free cash flow. Free cash flow covered dividend payments 13.3 times.
Summary generated from market data by MetaCap's automated system. Methodology
Astrana Health cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20172017-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 24.08M | 49.93M | 57.85M | 45.74M | 46.05M | 122.08M | 17.67M | 60.27M | 45.82M | -8.68M |
| Net Income growth (YoY) | -51.78% | -13.69% | +26.47% | -0.68% | -62.28% | +590.79% | -70.68% | +31.52% | — | -186.65% |
| Depreciation & Amortization | 45.75M | 27.93M | 17.75M | 17.54M | 17.52M | 18.35M | 18.28M | 19.30M | 19.08M | 645.74K |
| Stock-Based Compensation | 38.60M | 34.54M | 22.04M | 16.10M | 6.75M | 3.38M | 1.55M | 1.44M | 2.74M | 1.11M |
| Change in Working Capital | -13.54M | -75.04M | -17.87M | -38.49M | 170.00K | 6.81M | 5.26M | -22.93M | 201.02K | 864.17K |
| Operating Cash Flow | 114.60M | 52.20M | 68.23M | 82.13M | 70.33M | 46.16M | 13.67M | 25.50M | 51.83M | -8.14M |
| Capital Expenditures | -10.11M | -8.03M | -28.53M | -22.94M | -19.22M | -1.16M | -1.04M | -1.17M | -2.08M | -297.56K |
| Investing Cash Flow | -539.00M | -192.40M | -65.52M | -7.11M | 16.54M | 95.49M | -180.63M | -25.18M | 26.72M | -1.39M |
| Dividends Paid | -7.88M | -4.04M | -62.07M | -14.03M | -31.09M | -51.32M | -61.72M | -17.76M | -10.45M | — |
| Share Repurchases | -25.60M | -900.00K | -10.19M | -9.25M | -5.74M | -537.00K | -7.57M | -5.05M | -3.18M | — |
| Debt Issued | 1.12B | 171.88M | 284.53M | — | — | — | 250.00M | 8.00M | 5.00M | — |
| Debt Repaid | -495.29M | -18.50M | -204.68M | — | — | 0 | -2.38M | 0 | 0 | — |
| Financing Cash Flow | 569.35M | 135.15M | 3.42M | -20.09M | -47.75M | -51.70M | 163.33M | -11.18M | -14.98M | 8.92M |
| Net Change in Cash | 144.94M | -5.05M | 6.13M | 54.93M | 39.13M | 89.96M | -3.63M | -10.86M | 63.57M | -605.80K |
| Free Cash Flow | 104.49M | 44.17M | 39.70M | 59.19M | 51.11M | 45.00M | 12.63M | 24.33M | 49.75M | -8.44M |
This table shows 10 annual periods of Astrana Health's cash flow statement, from FY 2025 back to FY 2017, across 14 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow ASTH's reporting calendar. What is a cash flow statement?